Antrodin C Inhibits Epithelial-to-Mesenchymal Transition and Metastasis of Breast Cancer Cells via Suppression of Smad2/3 and β-Catenin Signaling Pathways - Kumar, K. J. Senthil; Vani, M. Gokila; Chueh, Pin-Ju; Mau, Jeng-Leun; Wang, Sheng-Yang (PloS one, 2015)
Keywords: Actin; Actin Cytoskeleton - drug effects; Actin Cytoskeleton - metabolism; Agricultural biotechnology; Antineoplastic Agents - chemistry; Antineoplastic Agents - isolation & purification; Antineoplastic Agents - pharmacology; Antrodia - chemistry; Antrodia - metabolism; Antrodia cinnamomea; Breast cancer; Breast carcinoma; Breast Neoplasms - metabolism; Breast Neoplasms - pathology; Cadherins - metabolism; Cancer; Cell adhesion & migration; Cell Movement - drug effects; Cell Survival - drug effects; Chemical agents; Chemotherapy; Cytoskeleton; Down-Regulation - drug effects; E-cadherin; Epithelial-Mesenchymal Transition - drug effects; Extracellular matrix; Female; Food; Food production; Gelatinase A; Humans; Insulin-like growth factors; Kinases; Maleimides - chemistry; Maleimides - isolation & purification; Maleimides - pharmacology; Markers; Matrix Metalloproteinase 2 - metabolism; Matrix Metalloproteinase 9 - metabolism; MCF-7 Cells; Mesenchyme; Metastases; Metastasis; N-Cadherin; Natural & organic foods; R&D; Regulators; Research & development; Signal transduction; Signal Transduction - drug effects; Signaling; Smad protein; Smad2 protein; Smad2 Protein - metabolism; Smad3 protein; Smad3 Protein - metabolism; Transforming Growth Factor beta1 - pharmacology; Transforming growth factor-b1; Tumors; U-Plasminogen activator; Up-Regulation - drug effects; Urokinase; Vimentin; Womens health; β-Catenin; United States--US; Taiwan; California